Shares in Generex Biotechnology Corporation (OTC: GNBT), a development stage company engaged in the research, development, and commercialization of drug delivery systems and technologies for metabolic and immunological disease, are soaring in trading today. At last check, GNBT shares were trading 22.51% higher at $0.0430 on volume of 4.04 million. The stock hit an intra-day high of $0.05 earlier today. GNBT shares have gained 35.38% in the last three trading sessions.
GNBT today announced that it will be filing an amendment to the Form S-1 Registration Statement it filed with the U.S. SEC on Tuesday.
Shares of NanoViricides Inc. (OTC: NNVC), a nano-biopharmaceutical company engaged in the discovery, development, and commercialization of therapeutics for the treatment of viral infections, are gaining in trading today. At last check, NNVC shares were trading 0.67% higher at $0.755 on volume of 202,833. The stock hit an intra-day high of $0.79 earlier today. NNVC shares have gained 7.86% in the last three trading sessions.
Earlier this week, NNVC announced that it submitted its letter of intent to file an Orphan Drug Application with the European Medicines Agency (EMA) for DengueCide™, which is the company’s drug candidate for the treatment of dengue and dengue hemorrhagic fever.
Shares of ALAS International Holdings Inc. (OTC: VDSC), a manufacturer of unmanned aerial vehicles (UAV) for federal and local governments, and the private sector, are climbing in trading today. At last check, VDSC shares were trading 12.96% higher at $0.0061 on volume of 6.02 million. The stock hit an intra-day high of $0.01 earlier today. VDSC shares have gained more than 48.70% in the last three trading sessions.
Earlier this week, ALAS announced the spinoff of its subsidiary IMAG Group Inc., which was previously known as Red Tide Defense Group.
Recent Comments